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Abstract15
The alkaloids from Chelidonium majus L. which had a significant inhibitory effect in mitochondrial respiration were those
which contain a positive charge due to a quaternary nitrogen atom, i.e., chelerythrine, sanguinarine, berberine and coptisine,
both with malate+glutamate or with succinate as substrates. When malate+glutamate was used as substrate, chelerythrine and
berberine, which contain methoxy groups, were particularly more active, since they had a strong effect even at low concentrations.
In submitochondrial particles, berberine and coptisine had a marked inhibitory effect on NADH dehydrogenase activity but
practically no effect on succinate dehydrogenase activity, whereas chelerythrine and sanguinarine inhibited more strongly
succinate dehydrogenase than NADH dehydrogenase, which is in agreement with the results found for mitochondrial respiration.
Protopine and allocryptopine, which did not inhibit mitochondrial respiration, strongly inhibited NADH dehydrogenase in
submitochondrial particles, but had no effect on succinate dehydrogenase activity.
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1. Introduction31
Chelidonium majus L. is a plant which grows in the32
wild in Southern and Central Europe, part of Asia,33
∗ Corresponding author. Tel.: +351-2966-50183;
fax: +351-2966-50171.
E-mail address: barreto@notes.uac.pt (M.C. Barreto).
North America and in the Azores archipelago (Kadan 34
et al., 1990; Pavão and Pinto, 1995; Colombo and 35
Bosisio, 1996). Its use as a medicinal plant is very 36
ancient (Paris and Moyse, 1967; Duke, 1985; Xème 37
Pharmacopée Française, 1989; Bézanger-Beauquesne 38
et al., 1990). The medicinal properties mentioned 39
above can be ascribed to the more than 27 alkaloids 40
present in the root and aerial part of the plant, which 41
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belong to three main groups (Fig. 1): (i) benzo[c]-42
phenanthridines, with two subgroups, (i.a) quaternary,43
like chelerythrine and sanguinarine or (i.b) tertiary,44
like chelidonine, (ii) protopine and derived thereof,45
such as protopine and allocryptopine, and (iii) proto-46
berberines such as berberine and coptisine (Lavenir47
and Paris, 1965; Táborská et al., 1994; Pavão and48
Pinto, 1995; Tomé and Colombo, 1995; Colombo and49
Bosisio, 1996). The interest of this plant for medic-50
inal purposes implies the need to know as much as51
possible about the effects on metabolic processes52
of the alkaloids it contains. Several alkaloids with53
the same or related structures have been found to54
interfere with respiration, either at the level of the55
electron transport chain (Schewe and Müller, 1976)56
or as uncouplers (Vallejos and Rizzotto, 1972). Since57
mitochondrial respiration is the core of metabolic58
energy, and therefore a process with major impor-59
tance, in the present work we investigated the effect60
of some of these alkaloids (Fig. 1) in respiration-61
linked processes. We selected alkaloids from each of62
the main groups found in the plants collected in S.63
Miguel Island, Azores (Pavão and Pinto, 1995). The64
effects of phenanthrene were also monitored, to allow65
for effects due only to the aromatic structure of the66
molecules.67
The aim of the present work is (a) to ascertain68
whether the effects detected follow a similar pattern69
within each group; (b) if any effect which occurs on70
oxygen uptake can be explained by events at the level71
of NADH dehydrogenase (NADH:ubiquinone oxi-72
doreductase, EC 1.6.99.3) or succinate dehydrogenase73
(succinate:ubiquinone oxidoreductase, EC 1.3.99.1).74
These two complexes were chosen by their crucial75
role in the respiratory chain and by evidence from76
other authors that these systems might be affected by77
compounds of this type (Schewe and Müller, 1976;78
McNaught et al., 1995, 1996).79
2. Materials and methods80
2.1. Animals81
The animals used were male albino mice, with ap-82
proximately 12 weeks of age and an average weight83
of 20–25 g. The animals were fed ad libitum with a84
commercial chow and tap water.85
2.2. Alkaloids 86
Chelidonine, berberine chloride and sanguinarine 87
chloride were purchased from Sigma. The other al- 88
kaloids were a kind gift from Prof. Slavik (Masaryk 89
University, Brno, Czech Republic). The alkaloids and 90
phenanthrene were used in methanolic solutions. The 91
effect of methanol was tested for all types of experi- 92
ment, in the range of volumes added to the assay me- 93
dia, and found to be negligible. 94
2.3. Preparation of mitochondria and 95
submitochondrial particles 96
Liver mitochondria and submitochondrial particles 97
were isolated according to a published method (Cain 98
and Skilleter, 1987). Protein concentrations were de- 99
termined using the Bradford Coomassie G250 dye pro- 100
cedure (Bradford, 1976) with bovine serum albumin 101
as standard. 102
2.4. Oxygen uptake by mitochondria 103
Oxygen uptake was monitored in a Hansatech 104
Clark-type electrode, model DW1 with a CB1 con- 105
trol box. Oxygen uptake by intact mitochondria was 106
monitored at 30 ◦C in the presence of either 10 mM 107
malate plus 10 mM glutamate or of 10 mM succinate. 108
The assay medium was 250 mM sucrose, 10 mM 109
Tris–HCl pH 7.4, 5 mM KH2PO4, 10 mM KCl, 5 mM 110
MgCl2 and 0.2 mM ADP (Cain and Skilleter, 1987). 111
Protein concentration was 0.5 mg/ml assay medium. 112
2.5. Enzyme activity assays 113
NADH and succinate dehydrogenase activities 114
were studied on submitochondrial particles, to avoid 115
permeability problems associated with the use of in- 116
tact mitochondria. Enzyme activities, modified from 117
methods described previously by other authors (Cénas 118
et al., 1991; Liu et al., 1991), were spectrophoto- 119
metrically monitored using a Shimadzu UV160A 120
split-beam spectrophotometer, at 30 ◦C in 10 mM 121
Tris–HCl pH 7.4, and with a protein concentration of 122
0.05 mg/ml. For NADH dehydrogenase the reaction 123
was started by the addition of 0.1 mM NADH and the 124
decrease in absorbance at 340 nm was registered. The 125
basal rate of oxidation of NADH during the time of the 126
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Fig. 2. Inhibition fractions (ε) of oxygen uptake by intact mitochondria in the presence of group (i.a) and (i.b) alkaloids. () Malate + glutamate (M + G), () succinate
(SUC) as substrates. Oxygen uptake was followed in a Clark-type electrode. Concentration of mitochondria was 0.5 mg protein/ml of assay medium. Results are presented
as mean ± S.D. (control values: chelerythrine, M+ G 16.6± 1.9 nmol O2/min mg, SUC 33.3± 2.6; sanguinarine, M+ G 17.4± 2.3, SUC 27.5± 2.6; chelidonine, M+ G
15.5± 2.0, SUC 32.2± 3.6).
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assay period was negligible. The medium for succi-127
nate dehydrogenase contained 0.001% dichloropheno-128
lindophenol; the reaction was started by the addition129
of 10 mM succinate and the decrease in absorbance at130
600 nm was followed.131
2.6. Treatment and presentation of results132
Results (media of at least three independent exper-133
iments) are presented as relative inhibitions or inhibi-134
tion degrees (ε), to minimize variability between dif-135
ferent mitochondrial extractions. ε was calculated as136
(v−vi)/v; v is defined as the rate of oxygen uptake or137
the rate of absorbance decrease at 340 or 600 nm, in138
the absence of inhibitor and vi the oxygen uptake or139
enzyme activity in the presence of an i concentration140
of inhibitor.141
3. Results142
3.1. Oxygen uptake by intact mitochondria143
The effects of the several groups of alkaloids on144
oxygen uptake in mitochondria showed different pat-145
terns. Chelerythrine and sanguinarine, both contain-146
Fig. 3. Inhibition fractions (ε) of oxygen uptake by intact mitochondria in the presence of group (ii) alkaloids. () Malate + glutamate
(M + G), () succinate (SUC), as substrates. Assay conditions were as described above. Results are presented as mean ± S.D. (control
values: protopine, M+ G 14.4± 0.7 nmol O2/min mg, SUC 26.4± 2.2; allocryptopine, M+ G 15.2± 2.0, SUC 27.9± 1.6).
ing a quaternary nitrogen atom with a methyl group, 147
strongly inhibited succinate-dependent respiration 148
and, to a lesser extent, malate–glutamate respira- 149
tion, while chelidonine, an uncharged phenanthridine 150
derivative, had virtually no effect (Fig. 2). Protopine 151
and allocryptopine, both uncharged and with a C=O 152
group, also had no apparent effect (Fig. 3). Berberine 153
and coptisine, both with an unsubstituted quaternary 154
nitrogen atom, had a marked inhibitory effect on 155
malate–glutamate respiration and a smaller, although 156
significant, effect on succinate respiration (Fig. 4). 157
Chelerythrine and berberine, which contain a quater- 158
nary nitrogen atom and methoxy substituents, showed 159
a stronger inhibitory effect of malate + glutamate 160
respiration at low concentrations, when compared, 161
with sanguinarine and coptisine, respectively (Figs. 2 162
and 4). Phenanthrene had a very low effect on oxygen 163
uptake (Fig. 5). 164
3.2. Enzyme activities in submitochondrial particles 165
In submitochondrial particles, chelerythrine and 166
sanguinarine inhibited succinate dehydrogenase ac- 167
tivity to a greater extent than NADH dehydrogenase 168
(Fig. 6). This is a type of pattern similar to the one 169
found on oxygen uptake (Fig. 2). Therefore, the ef- 170
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Fig. 4. Inhibition fractions (ε) of oxygen uptake by intact mitochondria in the presence of group (iii) alkaloids. () Malate + glutamate
(M + G), () succinate (SUC) as substrates. Assay conditions were as described above. Results are presented as mean ± S.D. (control
values: berberine, M+ G 17.5± 1.9 nmol O2/min mg, SUC 27.5± 4.2; coptisine, M+ G 14.7± 1.7, SUC 28.5± 3.5).
fect on mitochondrial respiration is essentially in171
the agreement with the effect on the two enzymes.172
Chelidonine caused a slight decrease on NADH de-173
hydrogenase but not on succinate dehydrogenase174
Fig. 5. Inhibition fractions (ε) of oxygen uptake by intact mitochon-
dria in the presence of phenanthrene. () Malate+ glutamate (M
+ G), () succinate (SUC) as substrates. Assay conditions were
as described above. Results are presented as mean±S.D. (control
values: M+ G 15.7± 1.9 nmol O2/min mg, SUC 27.8± 1.6).
activity (Fig. 6). Protopine and allocryptopine had a 175
very strong inhibitory effect on NADH dehydroge- 176
nase activity and did not affect succinate dehydroge- 177
nase (Fig. 7). Berberine and coptisine did not inhibit 178
NADH dehydrogenase so strongly as would be ex- 179
pected by their effect on oxygen uptake, and had no 180
effect on succinate dehydrogenase (Fig. 8). Phenan- 181
threne, although it did not affect oxygen uptake to a 182
great extent, had a marked inhibitory effect on NADH 183
dehydrogenase in submitochondrial particles but not 184
on succinate dehydrogenase (Fig. 9). 185
4. iscussion 186
The alkaloids with a charge due to a quaternary ni- 187
trogen atom presented a high inhibitory activity on 188
oxygen uptake (Figs. 2 and 4). Some authors have al- 189
ready observed that alkaloids containing a quaternary 190
nitrogen atom are the ones with the highest biological 191
activity (Ulrichová et al., 1984; Dostál and Potácek, 192
1990; McNaught et al., 1995, 1996). 193
The alkaloids which contain a methyl group linked 194
to the quaternary nitrogen atom seemed to have a 195
more significant effect on succinate-dependent pro- 196
cesses (Figs. 2 and 6). Berberine and coptisine had 197
practically no effect on succinate dehydrogenase 198
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Fig. 6. Inhibition fractions (ε) of NADH dehydrogenase, NADH DH () and succinate dehydrogenase, SDH (), in the presence of group (i) alkaloids. Enzyme activities
were spectrophotometrically monitored at 340 nm (NADH DH) and at 600 nm (SDH). Concentration of SMPs was 0.05 mg protein/ml of assay medium. Results are
presented as mean ± S.D. (control values: chelerythrine, NADH DH 0.317± 0.014mol NADH/min mg, SDH 0.075± 0.002mol succinate/min mg; sanguinarine, NADH
DH 0.235± 0.016, SDH 0.073± 0.002; chelidonine, NADH DH 0.352± 0.001, SDH 0.095± 0.001).
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Fig. 7. Inhibition fractions (ε) of NADH dehydrogenase, NADH DH () and succinate dehydrogenase, SDH (), in the presence of
group (ii) alkaloids. Assay conditions were as described above. Results are presented as mean ± S.D. (control values: protopine, NADH
DH 0.293 ± 0.018mol NADH/min mg, SDH 0.071 ± 0.005mol succinate/min mg; allocryptopine, NADH DH 0.286 ± 0.023, SDH
0.074± 0.005).
activity, although the inhibition of succinate-dependent199
oxygen uptake was quite marked. The pattern we ob-200
served in submitochondrial particles agreed with the201
results reported in another study (Schewe and Müller,202
1976), which reports the effect of berberine on NADH203
oxidase and succinate–cytochrome c oxidoreductase204
Fig. 8. Inhibition fractions (ε) of NADH dehydrogenase, NADH DH () and succinate dehydrogenase, SDH (), in the presence of group
(iii) alkaloids. Assay conditions were as described above. Results are presented as mean ± S.D. (control values: berberine, NADH DH
0.338±0.016mol NADH/min mg, SDH 0.116±0.004mol succinate/min mg; coptisine, NADH DH 0.337±0.009, SDH 0.087±0.002).
in beef heart submitochondrial particles. The authors 205
found that berberine had a strong inhibitory effect on 206
NADH oxidase and a much lower effect on succinate 207
dehydrogenase activity. 208
In the present work, the effects of the group i and ii 209
alkaloids tested on NADH dehydrogenase were very
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Fig. 9. Inhibition fractions (ε) of NADH dehydrogenase, NADH
DH () and succinate dehydrogenase, SDH (), in the presence
of phenanthrene. Assay conditions were as described above. Re-
sults are presented as mean ± S.D. (control values: NADH DH
0.286±0.024mol NADH/min mg, SDH 0.075±0.003mol suc-
cinate/min mg).
similar. The fact that chelidonine, protopine and al-210
locryptopine, bearing no charge, inhibited NADH de-211
hydrogenase but had practically no effect in intact mi-212
tochondria, may have been due to the abolition of per-213
meability barriers, since NADH dehydrogenase faces214
the inner side of the membrane in intact mitochon-215
dria and the outer side in submitochondrial particles216
(Harmon et al., 1974).217
The comparative analysis between the results of res-218
piration and of enzyme activities suggests that the un-219
charged compounds we tested had more difficulty in220
passing across the mitochondrial membrane to gain ac-221
cess to the enzyme molecules. The analysis of results222
reported by another research group (McNaught et al.,223
1995, 1996) corroborate this hypothesis. These authors224
reported that isoquinolinium cations were more active225
inhibitors of respiration in intact mitochondria than226
isoquinolines. In mitochondrial fragments, the pres-227
ence of a quaternary atom was not essential for the in-228
hibition of complex I activity (McNaught et al., 1995,229
1996). This is probably correct since we found that230
protopine and allocryptopine produced a marked ef-231
fect on NADH dehydrogenase. The differences found232
between mitochondria and mitochondrial fragments233
may be explained by a preferential transport and ac- 234
cumulation of the cations as opposed to the uncharged 235
isoquinoline molecules. The high membrane poten- 236
tial in mitochondria may result in a selective attrac- 237
tion of lipophilic cations, leading to their accumula- 238
tion on the matrix side (Ramsay and Singer, 1986; 239
Ramsay et al., 1987; Murphy, 1997). The concentra- 240
tion of positively charged alkaloids in intact mitochon- 241
dria may therefore be much higher than the concen- 242
tration of the other substances tested in the present 243
work. 244
The presence of a quaternary atom is not enough 245
to confer inhibitory activity to molecules, since am- 246
monium acetate, tetramethylammonium iodide and 247
tetrapropylammonium iodide had no effect on en- 248
zyme activity (results not shown). Phenanthrene, with 249
a full aromatic structure and no substituents, caused 250
a decrease on NADH dehydrogenase activity (Fig. 9). 251
NADH dehydrogenase inhibition may be associated 252
with the presence of at least two adjacent aromatic 253
rings, which are present in berberine, coptisine, chel- 254
erythrine and sanguinarine structures (Figs. 6 and 8). 255
Inhibition by protopine and allocryptopine is likely 256
due to the carbonyl group, which may react with 257
catalytically important SH groups in the enzyme 258
molecule or perhaps with the iron–sulfur clusters of 259
complex I. 260
The presence of four consecutive aromatic groups 261
and a positive charge, which exist in chelerythrine and 262
sanguinarine, may be a structure associated with the 263
inhibition of succinate dehydrogenase. The positive 264
charge is probably necessary, since phenanthrene, with 265
the same aromatic rings but with no charge, did not 266
inhibit this enzyme. Many observed biological effects 267
of these two alkaloids involve the formation of a labile 268
covalent bond between SH groups of cell components 269
and the electrophilic C6 carbon (Sedo et al., 2002). The 270
imminium bond in sanguinarine and chelerythrine is 271
susceptible to a nucleophilic attack and consequently 272
plays a key role in the inhibition of SH proteins. The 273
fact that hepatocytes incubated with these two alka- 274
loids suffered a dose-dependent GSH depletion cor- 275
roborates the idea that they bind to this SH peptide 276
(Ulrichová et al., 2001). 277
The presence of methoxy groups also contributes 278
to the difference in the inhibition strength of malate– 279
glutamate-dependent oxygen uptake at low alkaloid 280
concentrations between the positively charged alka- 281
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loids which contain methoxy groups and those where282
they are absent (chelerythrine versus sanguinarine283
and berberine versus coptisine, Figs. 2 and 4). This284
may be due to an easier passage of these alkaloids285
across the membrane and/or to an increased inhibi-286
tion of NADH dehydrogenase, in the case of ber-287
berine.288
Berberine, containing both a quaternary nitrogen289
atom and methoxy groups, was the most biologically290
active of all the alkaloids tested, and therefore it should291
have the highest toxicity.292
We suggest that the biological effects of the alka-293
loids on mitochondria are due to (i) the positive charge294
of the alkaloids, which causes their accumulation in-295
side the organelle and (ii) inhibition of both NADH296
and/or succinate dehydrogenase activity and probably297
also inhibition at the cytochrome level, since in some298
cases the effects on respiration are not fully explained299
by the effects on the enzymes. This is corroborated by300
preliminary results from our laboratory (unpublished301
data) which show that berberine inhibits cytochrome302
aa3 reduction.303
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